LOXL2 and cancer: Studies have shown, in a variety of cancers, that increased expression of LOXL2 is related to epithelial-mesenchymal transition, tumor development, invasion, and metastasis and is a marker of epithelial-mesenchymal transition and poor prognosis (3, 4, 5).